Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Nuwellis, Inc.

Get SEC filing alerts via email and in your feed for Nuwellis, Inc.

NUWE NUWEW

Nuwellis, Inc.

About Nuwellis, Inc.

Nuwellis, Inc. develops and commercializes medical devices for fluid management, primarily ultrafiltration systems like Aquadex, used to treat fluid overload in heart failure, critical care, and pediatric patients. Its products enable safe, precise fluid removal, improving clinical outcomes and reducing hospital readmissions. Serving hospitals and healthcare providers worldwide, the company focuses on innovation, clinical evidence, and regulatory compliance to enhance patient care and healthcare economics.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Nuwellis, Inc.

1
1
Nuwellis, Inc. Nuwellis Reports 26.2% Revenue Growth but Wider Net Loss in Q1 2026

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
Nuwellis, Inc. Nuwellis Reports $17.5 Million Net Loss for Fiscal Year 2025 Amid Revenue Decline

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Nuwellis, Inc. Nuwellis Reports Q3 2025 Financial Results with $2.2M in Net Sales and Increased Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Nuwellis, Inc. Nuwellis Reports 21.4% Decline in Q2 2025 Net Sales, Increases Losses

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Nuwellis, Inc. Nuwellis Reports 2.5% Revenue Growth to $1.9 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Nuwellis, Inc. Nuwellis Reports $11.2 Million Net Loss for Fiscal Year 2024, Sees Revenue Decline

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Nuwellis, Inc. Nuwellis Reports Improved Financials, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments